s6y

3 Aclaris Therapeutics, Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001193805-18-001272

Documents

  1. e618011_3-aclaris.xml 3
  2. e618011_ex99.htm EX-99

On sec.gov